Optimizing Autologous Therapies: Commercial & CMC Learnings, Smarter Trials, and Strategic Indication Expansion
18 Sep 2025
Autologous Therapies in Solid Tumors and Beyond
- Commercial Lessons from the Front Line: Real-world insights from autologous therapy launches to refine patient access, pricing, and CMC scalability & network strategies.
- Trial Design for Personalized Products: Overcoming challenges in small patient populations and manufacturing constraints through innovative trial frameworks.
- Expanding into New Indications: Balancing scientific rationale with commercial viability to identify and prioritize pipeline opportunities.
